Answers to your questions about the VenaFlux Solutions : Frequently Asked Questions (FAQs)


- Oct 22
- 4 min
The rate of platelet activation determines thrombus size and structure at arterial shear

- Oct 9
- 3 min
New insights into prothrombotic state of post-COVID syndrome patients

- Oct 2
- 3 min
Maximising Efficiency and Performance: Using UniGo and ExiGo Pumps Together

- Sep 20
- 3 min
Chronic platelet activation contributes to Alzheimers Disease and its progression

- Jun 26
- 4 min
Bacteriology: E. Coli; Adhesion; Biofilm Formation

- May 23
- 2 min
Getting started with Cellix's Vena8 Glass Coverslip Biochips

- May 8
- 1 min
VenaDeltaY Biochips: for dual flow / dual injection of samples

- Apr 24
- 3 min
VenaT4 Biochip: for cell migration, transmigration, invasion and chemotaxis studies


- Apr 17
- 3 min
Vena8 Fluoro+ Biochip: for cell receptor–ligand studies with conditions mimicking physiological flow

- Apr 11
- 3 min
Getting started with Cellix's Vena8 Endothelial+ biochip

- Mar 13
- 3 min
Intravenous abciximab as a rescue therapy in stroke patients

- Mar 6
- 3 min
How to conduct a thrombosis assay using Mirus Evo or ExiGo Pump?


- Feb 27
- 4 min
VenaFlux Solutions for Thrombosis assay : How does it work?

- Feb 20
- 3 min
VenaFlux for thrombosis: Installation and training guide

- Feb 14
- 4 min
Interference of C604 on platelet aggregation pathways

- Jan 30
- 2 min
VenaFlux : Accessories required to conduct a thrombosis assay using the VenaFlux setup

- Jan 23
- 3 min
Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel


- Jan 16
- 5 min
Cardiovascular: Platelets - Thrombosis Adhesion Assay

- Nov 22, 2022
- 3 min
A role for SHARPIN in platelet linear protein ubiquitination and function – By Moore et al. (2021).